Subsequently, in this work, we for the first time showed that HtrA4 reduces survival of adenocarcinoma cells treated with chemotherapeutic drugs (Figure 3A,B) and promotes cancer cell death by enhancing apoptosis (Figure 4 and Figure 5A, Table 2). This evidence concerns the gene HTRA4 and adenocarcinoma.